1. Home
  2. PRQR vs GAU Comparison

PRQR vs GAU Comparison

Compare PRQR & GAU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRQR
    SELLHOLDBUYas of 15 hours ago
  • GAU
    SELLHOLDBUYas of 15 hours ago
  • Stock Information
  • Founded
  • PRQR 2012
  • GAU 1999
  • Country
  • PRQR Netherlands
  • GAU Canada
  • Employees
  • PRQR N/A
  • GAU N/A
  • Industry
  • PRQR Biotechnology: Pharmaceutical Preparations
  • GAU
  • Sector
  • PRQR Health Care
  • GAU
  • Exchange
  • PRQR Nasdaq
  • GAU Nasdaq
  • Market Cap
  • PRQR 309.5M
  • GAU 323.9M
  • IPO Year
  • PRQR 2014
  • GAU N/A
  • Fundamental
  • Price
  • PRQR $1.18
  • GAU $1.06
  • Analyst Decision
  • PRQR Strong Buy
  • GAU Strong Buy
  • Analyst Count
  • PRQR 6
  • GAU 1
  • Target Price
  • PRQR $8.50
  • GAU $2.80
  • AVG Volume (30 Days)
  • PRQR 709.6K
  • GAU 840.9K
  • Earning Date
  • PRQR 05-08-2025
  • GAU 05-01-2025
  • Dividend Yield
  • PRQR N/A
  • GAU N/A
  • EPS Growth
  • PRQR N/A
  • GAU N/A
  • EPS
  • PRQR N/A
  • GAU 0.02
  • Revenue
  • PRQR $20,235,014.00
  • GAU $231,339,000.00
  • Revenue This Year
  • PRQR $6.44
  • GAU $58.96
  • Revenue Next Year
  • PRQR N/A
  • GAU $39.24
  • P/E Ratio
  • PRQR N/A
  • GAU $53.50
  • Revenue Growth
  • PRQR 196.41
  • GAU N/A
  • 52 Week Low
  • PRQR $1.15
  • GAU $1.06
  • 52 Week High
  • PRQR $4.62
  • GAU $2.00
  • Technical
  • Relative Strength Index (RSI)
  • PRQR 20.57
  • GAU 35.30
  • Support Level
  • PRQR $1.25
  • GAU $1.22
  • Resistance Level
  • PRQR $1.39
  • GAU $1.19
  • Average True Range (ATR)
  • PRQR 0.09
  • GAU 0.06
  • MACD
  • PRQR -0.02
  • GAU -0.02
  • Stochastic Oscillator
  • PRQR 0.00
  • GAU 0.66

Stock Price Comparison Chart: PRQR vs GAU

PRQR
GAU
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April0123456789PRQR VS GAU

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.

About GAU Galiano Gold Inc.

Galiano Gold Inc is focused on building a sustainable business capable of long term value creation for its stakeholders through a combination of exploration, accretive acquisitions, and disciplined deployment of its financial resources. The company currently operates and manages the Asanko Gold Mine, located in Ghana, West Africa. Its Asanko Gold Mine is a multi-deposit complex, with two main deposits, the Obotan Project and the Esaase Project, both located in the Amansie West District of the Republic of Ghana, West Africa.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use